Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alejandra Estevez is active.

Publication


Featured researches published by Alejandra Estevez.


Emerging Infectious Diseases | 2011

Bartonella spp. in Bats, Guatemala

Ying Bai; Michael Y. Kosoy; Sergio Recuenco; Danilo Alvarez; David Moran; Amy S. Turmelle; James A. Ellison; Daniel L. Garcia; Alejandra Estevez; Kim A. Lindblade; Charles E. Rupprecht

To better understand the role of bats as reservoirs of Bartonella spp., we estimated Bartonella spp. prevalence and genetic diversity in bats in Guatemala during 2009. We found prevalence of 33% and identified 21 genetic variants of 13 phylogroups. Vampire bat–associated Bartonella spp. may cause undiagnosed illnesses in humans.


Influenza and Other Respiratory Viruses | 2010

Population‐based surveillance for 2009 pandemic influenza A (H1N1) virus in Guatemala, 2009

Lissette Reyes; Wences Arvelo; Alejandra Estevez; Jennifer Gray; Juan Carlos Moir; Betty Gordillo; Gal Frenkel; Francisco Ardón; Fabiola Moscoso; Sonja J. Olsen; Alicia M. Fry; Steve Lindstrom; Kim A. Lindblade

Please cite this paper as: Reyes et al. (2010) Population‐based surveillance for 2009 pandemic influenza A (H1N1) virus in Guatemala, 2009. Influenza and Other Respiratory Viruses 4(3), 129–140.


Journal of Clinical Virology | 2012

Norovirus outbreak of probable waterborne transmission with high attack rate in a Guatemalan resort

Wences Arvelo; Silvia M. Sosa; Patricia Juliao; Maria Renee Lopez; Alejandra Estevez; Beatriz López; María E. Morales-Betoulle; Miguel González; Nicole Gregoricus; Aron J. Hall; Jan Vinjé; Umesh D. Parashar; Kim A. Lindblade

BACKGROUND In February 2009, a group of Guatemalan school children developed acute gastroenteritis (AGE) after participating in a school excursion. OBJECTIVES We conducted a retrospective cohort investigation to characterize the outbreak and guide control measures. STUDY DESIGN A case was defined as an illness with onset of diarrhea or vomiting during February 25-March 5, 2009. Participants were interviewed using a standardized questionnaire, and stool specimens were collected. We inspected the excursion site and tested water samples for total coliforms and Escherichia coli. RESULTS We identified 119 excursion participants, of which 92 (77%) had been ill. Fifty-six (62%) patients sought care for their illness, and three (3%) were hospitalized. Eighteen (90%) of the 20 specimens from ill children tested positive for norovirus. Among these, 16 (89%) were of the genogroup I (GI.7) and two (11%) were genogroup II (GII.12 and GII.17). One (8%) of the 12 food handlers had norovirus (GI.7). Drinking water samples had 146 most probable numbers (MPN)/100ml of total coliforms and five MPN/100ml of E. coli. CONCLUSION We describe the first laboratory-confirmed norovirus outbreak in Guatemala. The high illness attack rate, detection of multiple norovirus strains in sick persons, and presence of fecal contamination of drinking water indicate likely waterborne transmission.


PLOS ONE | 2010

A Comparison of the Epidemiology and Clinical Presentation of Seasonal Influenza A and 2009 Pandemic Influenza A (H1N1) in Guatemala

Kim A. Lindblade; Wences Arvelo; Jennifer Gray; Alejandra Estevez; Gal Frenkel; Lissette Reyes; Fabiola Moscoso; Juan Carlos Moir; Alicia M. Fry; Sonja J. Olsen

Background A new influenza A (H1N1) virus was first found in April 2009 and proceeded to cause a global pandemic. We compare the epidemiology and clinical presentation of seasonal influenza A (H1N1 and H3N2) and 2009 pandemic influenza A (H1N1) (pH1N1) using a prospective surveillance system for acute respiratory disease in Guatemala. Methodology/Findings Patients admitted to two public hospitals in Guatemala in 2008–2009 who met a pneumonia case definition, and ambulatory patients with influenza-like illness (ILI) at 10 ambulatory clinics were invited to participate. Data were collected through patient interview, chart abstraction and standardized physical and radiological exams. Nasopharyngeal swabs were taken from all enrolled patients for laboratory diagnosis of influenza A virus infection with real-time reverse transcription polymerase chain reaction. We identified 1,744 eligible, hospitalized pneumonia patients, enrolled 1,666 (96%) and tested samples from 1,601 (96%); 138 (9%) had influenza A virus infection. Surveillance for ILI found 899 eligible patients, enrolled 801 (89%) and tested samples from 793 (99%); influenza A virus infection was identified in 246 (31%). The age distribution of hospitalized pneumonia patients was similar between seasonal H1N1 and pH1N1 (P = 0.21); the proportion of pneumonia patients <1 year old with seasonal H1N1 (39%) and pH1N1 (37%) were similar (P = 0.42). The clinical presentation of pH1N1 and seasonal influenza A was similar for both hospitalized pneumonia and ILI patients. Although signs of severity (admission to an intensive care unit, mechanical ventilation and death) were higher among cases of pH1N1 than seasonal H1N1, none of the differences was statistically significant. Conclusions/Significance Small sample sizes may limit the power of this study to find significant differences between seasonal influenza A and pH1N1. In Guatemala, influenza, whether seasonal or pH1N1, appears to cause severe disease mainly in infants; targeted vaccination of children should be considered.


The Journal of Infectious Diseases | 2013

Respiratory Syncytial Virus Infection in Guatemala, 2007–2012

John McCracken; Mila M. Prill; Wences Arvelo; Kim A. Lindblade; Maria Renee Lopez; Alejandra Estevez; Maria L. Müller; Fredy Muñoz; Christopher Bernart; Margarita Cortez; Juan Carlos Moir; José Ortíz; Antonio Paredes; Marika K. Iwane

BACKGROUND Respiratory syncytial virus (RSV) is a major cause of acute respiratory illness (ARI). Little is known about RSV disease among older children and adults in Central America. METHODS Prospective surveillance for ARI among hospital patients and clinic patients was conducted in Guatemala during 2007-2012. Nasopharyngeal and oropharyngeal swab specimens were tested for RSV, using real-time reverse-transcription polymerase chain reaction. RESULTS Of 6287 hospitalizations and 2565 clinic visits for ARI, 24% and 12%, respectively, yielded RSV-positive test results. The incidence of RSV-positive hospitalization for ARI was 5.8 cases/10 000 persons per year and was highest among infants aged <6 months (208 cases/10 000 persons per year); among adults, the greatest incidence was observed among those aged ≥ 65 years (2.9 cases/10 000 persons per year). The incidence of RSV-positive clinic visitation for ARI was 32 cases/10 000 persons per year and was highest among infants aged 6-23 months (186 cases/10 000 persons per year). Among RSV-positive hospital patients with ARI, underlying cardiovascular disease was associated with death, moribund discharge, intensive care unit admission, or mechanical ventilation (odds ratio, 4.1; 95% confidence interval, 1.9-8.8). The case-fatality proportion among RSV-positive hospital patients with ARI was higher for those aged ≥ 5 years than for those aged <5 years (13% vs 3%; P < .001). CONCLUSIONS The incidences of RSV-associated hospitalization and clinic visitation for ARI were highest among young children, but a substantial burden of ARI due to RSV was observed among older children and adults.


American Journal of Tropical Medicine and Hygiene | 2012

Rickettsia felis in Ctenocephalides felis from Guatemala and Costa Rica

Adriana Troyo; Danilo Alvarez; Lizeth Taylor; Gabriela Abdalla; Olger Calderón-Arguedas; Maria L. Zambrano; Kim A. Lindblade; Laya Hun; Marina E. Eremeeva; Alejandra Estevez

Rickettsia felis is an emerging human pathogen associated primarily with the cat flea Ctenocephalides felis. In this study, we investigated the presence of Rickettsia felis in C. felis from Guatemala and Costa Rica. Ctenocephalides felis were collected directly from dogs and cats, and analyzed by polymerase chain reaction for Rickettsia-specific fragments of 17-kDa protein, OmpA, and citrate synthase genes. Rickettsia DNA was detected in 64% (55 of 86) and 58% (47 of 81) of flea pools in Guatemala and Costa Rica, respectively. Sequencing of gltA fragments identified R. felis genotype URRWXCal(2) in samples from both countries, and genotype Rf2125 in Costa Rica. This is the first report of R. felis in Guatemala and of genotype Rf2125 in Costa Rica. The extensive presence of this pathogen in countries of Central America stresses the need for increased awareness and diagnosis.


Journal of Medical Virology | 2013

Prevalence and Genetic Diversity of Norovirus Among Patients With Acute Diarrhea in Guatemala

Alejandra Estevez; Wences Arvelo; Aron J. Hall; Maria Renee Lopez; Beatriz López; Lissette Reyes; Juan Carlos Moir; Nicole Gregoricus; Jan Vinjé; Umesh D. Parashar; Kim A. Lindblade

Noroviruses (NoVs) are a leading cause of acute gastroenteritis outbreaks and sporadic cases of diarrhea in industrialized countries. To study the prevalence and genetic diversity of NoVs in Guatemala, stool specimens were collected from hospitalized and ambulatory patients presenting with diarrhea (≥3 loose or liquid stools in a 24‐hr period) who were enrolled in a prospective surveillance system in the Departments of Santa Rosa (October 2007 to August 2010) and Quetzaltenango (August 2009 to August 2010), Guatemala. Specimens were tested for rotavirus, enteric bacteria, and parasites by routine methods and for genogroups I and II NoV by real‐time reverse transcription‐PCR. A total of 2,403 stool specimens were collected from hospitalized (n = 528) and ambulatory patients (n = 1,875). Overall, 341 (14%) samples tested positive for NoVs including 114 (22%) hospitalized and 227 (12%) ambulatory patients. NoVs disease peaked during the winter (November–January) months. Among the 341 NoVs‐positive patients, 32 (9%) were also positive for rotavirus, 32 (9%) for bacteria, and 9 (3%) for protozoa. Nucleotide sequences were obtained from 84 samples collected from hospitalized children aged <5 years of age, which could be grouped into nine GII and three GI genotypes with GII.4 (74%) and GI.8 (10%) being the most common. This is the first study on the prevalence of NoVs among hospitalized and ambulatory patients with diarrhea in Guatemala. The findings highlight the need to implement laboratory diagnostics for NoVs to improve appropriate clinical management of diarrheal diseases and guide vaccine development. J. Med. Virol. 85:1293–1298, 2013.


Journal of Clinical Virology | 2013

Diagnostic performance of rectal swab versus bulk stool specimens for the detection of rotavirus and norovirus: implications for outbreak investigations.

Wences Arvelo; Aron J. Hall; Alejandra Estevez; Beatriz López; Nicole Gregoricus; Jan Vinjé; Jon R. Gentsch; Umesh D. Parashar; Kim A. Lindblade

BACKGROUND In January of 2008, during the peak of the rotavirus season in Guatemala, a gastroenteritis outbreak with high mortality among infants was reported in Guatemala. Despite extensive efforts, the investigation was limited by the lack of bulk stool specimens collected, particularly from the more severely dehydrated or deceased children. OBJECTIVES We evaluated the diagnostic performance of rectal swab specimens compared with bulk stool for the detection of rotavirus and norovirus. STUDY DESIGN Patients with diarrhea (≥3 loose stools in 24 h) were enrolled through an ongoing surveillance system in Guatemala. From January through March 2009, we attempted to enroll 100 patients <5 years old captured by the diarrhea surveillance, and collected paired bulk stool and rectal swabs specimens from them. Specimens were tested for norovirus using real-time reverse transcription-polymerase chain reaction and for rotavirus via enzyme immunoassay. RESULTS We enrolled 102 patients with paired specimens; 91% of 100 paired specimens tested for rotavirus yielded concordant results positive for rotavirus with a negativity rate of 83%. Among 100 paired specimens tested for norovirus, 86% were concordant norovirus detection and the negativity rate was 85%. The diagnostic performance for rotavirus and norovirus detection did not differ significantly between the two specimen types. CONCLUSIONS Testing of properly collected fecal specimens using rectal swabs may be a viable alternative to bulk stool for detection of rotavirus and norovirus, particularly during outbreaks where collection of bulk stool may be difficult.


Influenza and Other Respiratory Viruses | 2014

Comparative epidemiology of human metapneumovirus- and respiratory syncytial virus-associated hospitalizations in Guatemala

John McCracken; Wences Arvelo; José Ortíz; Lissette Reyes; Jennifer Gray; Alejandra Estevez; Oscar Castañeda; Gayle Langley; Kim A. Lindblade

Human metapneumovirus (HMPV) is an important cause of acute respiratory infections (ARI), but little is known about how it compares with respiratory syncytial virus (RSV) in Central America.


Clinical Infectious Diseases | 2018

Incidence and Clinical Profile of Norovirus Disease in Guatemala, 2008–2013

Marieke Bierhoff; Wences Arvelo; Alejandra Estevez; Joe P. Bryan; John McCracken; Maria Renee Lopez; Beatriz López; Umesh D. Parashar; Kim A. Lindblade; Aron J. Hall

Background Acute gastroenteritis (AGE) is a leading infectious cause of morbidity worldwide, particularly among children in developing countries. With the decline of rotavirus disease rates following introduction of rotavirus vaccines, the relative importance of norovirus will likely increase. Our objectives in this study were to determine the incidence and clinical profile of norovirus disease in Guatemala. Methods We analyzed data from a population-based surveillance study conducted in Guatemala from 2008 through 2013. Demographic information, clinical data, and stool samples were collected from patients who presented with AGE (≥3 liquid stools within 24 hours that initiated 7 days before presentation). Estimated incidence of hospitalized, outpatient, and total community norovirus disease was calculated using surveillance data and household surveys of healthcare use. Results We included 999 AGE hospitalizations and 3189 AGE outpatient visits at facilities, of which 164 (16%) and 370 (12%), respectively, were positive for norovirus. Severity of norovirus was milder than of rotavirus. Community incidence of norovirus ranged from 2068 to 4954 per 100000 person-years (py) in children aged<5 years. Children aged <5 years also had higher incidence of norovirus-associated hospitalization (51-105 per 100000 py) compared with patients aged ≥5 years (0-1.6 per 100000 py and 49-80 per 100000 py, respectively). Conclusions This study highlights the burden of norovirus disease in Guatemala, especially among young children. These data can help prioritize development of control strategies, including the potential use of vaccines, and provide a baseline to evaluate the impact of such interventions.

Collaboration


Dive into the Alejandra Estevez's collaboration.

Top Co-Authors

Avatar

Kim A. Lindblade

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Wences Arvelo

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Lissette Reyes

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Beatriz López

Universidad del Valle de Guatemala

View shared research outputs
Top Co-Authors

Avatar

Jennifer Gray

Universidad del Valle de Guatemala

View shared research outputs
Top Co-Authors

Avatar

Maria Renee Lopez

Universidad del Valle de Guatemala

View shared research outputs
Top Co-Authors

Avatar

Aron J. Hall

National Center for Immunization and Respiratory Diseases

View shared research outputs
Top Co-Authors

Avatar

Umesh D. Parashar

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Gal Frenkel

Universidad del Valle de Guatemala

View shared research outputs
Top Co-Authors

Avatar

John McCracken

Universidad del Valle de Guatemala

View shared research outputs
Researchain Logo
Decentralizing Knowledge